Literature DB >> 19198576

Crohn's disease phenotype, prognosis, and long-term complications: what to expect?

Jacques Cosnes1.   

Abstract

According to Montreal classification, different phenotypes of Crohn's disease are defined taking into account age at diagnosis, localization of digestive lesions at first surgery, and cumulative anatomical behaviour. This classification is supported by the increased severity of the disease when diagnosed in childhood, the relative stability of disease localization over time, and the clinical importance of intestinal complications as stricture and abscess or fistula formation. However, type and delay of complications are dependent on disease localization (they develop early in small bowel disease and late in colitis), every patient will develop complications one day, and perianal disease may be an important problem observed in up to half the patients. The percentage of patients with active disease every year remains stable, about 40%, after the 3 first years, and only a few patients have long periods of remission. Intestinal resections are required in the majority of patients during life, and many are operated on several times. Prognosis is hampered by iterative surgery, cancer and side-effects of treatment. Standardized mortality ratio is 1.50. Although occurrence of complications, need for surgery and mortality did not change significantly through the years 1950-2000, there are some signals suggesting that new therapetic strategies (immunosuppressants earlier in high risk patients) and biologics will modify natural history and improve the long-term prognosis.

Entities:  

Mesh:

Year:  2008        PMID: 19198576

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  8 in total

1.  Endoscopic management of inflammatory bowel disease strictures.

Authors:  Raluca Vrabie; Gerald L Irwin; David Friedel
Journal:  World J Gastrointest Endosc       Date:  2012-11-16

2.  Risk factors for initial surgery in patients with Crohn's disease in Central China.

Authors:  Min Chen; Fengming Yi; Feng Zhou; Meifang Huang; Jin Li; Wenfeng Yan; Lixia Li; Bing Xia
Journal:  Surg Today       Date:  2014-12-20       Impact factor: 2.549

3.  Predictors of clinical and endoscopic findings in differentiating Crohn's disease from intestinal tuberculosis.

Authors:  Xuefeng Li; Xiaowei Liu; Yiyou Zou; Chunhui Ouyang; Xiaoping Wu; Minghuan Zhou; Linlin Chen; Lingjuan Ye; Fanggen Lu
Journal:  Dig Dis Sci       Date:  2010-05-14       Impact factor: 3.199

Review 4.  Surgery and diagnostic imaging in abdominal Crohn's disease.

Authors:  Fiorenzo Botti; Flavio Caprioli; Diego Pettinari; Alberto Carrara; Andrea Magarotto; Ettore Contessini Avesani
Journal:  J Ultrasound       Date:  2013-10-16

5.  Intestinal healing after anti-TNF induction therapy predicts long-term response to one-year treatment in patients with ileocolonic Crohn's disease naive to anti-TNF agents.

Authors:  Piotr Eder; Liliana Łykowska-Szuber; Katarzyna Katulska; Kamila Stawczyk-Eder; Iwona Krela-Kaźmierczak; Katarzyna Klimczak; Aleksandra Szymczak; Marek Stajgis; Krzysztof Linke
Journal:  Prz Gastroenterol       Date:  2015-11-04

Review 6.  Nutritional Treatment in Crohn's Disease.

Authors:  Giacomo Caio; Lisa Lungaro; Fabio Caputo; Eleonora Zoli; Fiorella Giancola; Giuseppe Chiarioni; Roberto De Giorgio; Giorgio Zoli
Journal:  Nutrients       Date:  2021-05-12       Impact factor: 5.717

7.  IL-10 treatment is associated with prohibitin expression in the Crohn's disease intestinal fibrosis mouse model.

Authors:  C Yuan; W-X Chen; J-S Zhu; N-W Chen; Y-M Lu; Y-X Ou; H-Q Chen
Journal:  Mediators Inflamm       Date:  2013-04-14       Impact factor: 4.711

Review 8.  Medical Therapy of Fibrostenotic Crohn's Disease.

Authors:  Britta Siegmund
Journal:  Viszeralmedizin       Date:  2015-07-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.